NCT02084602View on ClinicalTrials.gov

Assessment of Artesunate/Mefloquine in the Peruvian Amazon

PHASE4CompletedINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

June 18, 2014

Primary Completion Date

November 6, 2015

Study Completion Date

April 13, 2016

Conditions
Malaria, Falciparum
Interventions
DRUG

Artesunate

Orally administration of artesunate 4mg/Kg by three days

DRUG

Mefloquine

Orally administration of mefloquine 15mg/Kg in the fourth day Orally administration of mefloquine 10mg/Kg in the fifth day

Trial Locations (1)

5116

NAMRU 6, Iquitos

All Listed Sponsors
collaborator

U.S. Naval Medical Research Unit No.6 (NAMRU-6)

UNKNOWN

lead

Instituto Nacional de Salud. Peru

OTHER_GOV

NCT02084602 - Assessment of Artesunate/Mefloquine in the Peruvian Amazon | Biotech Hunter | Biotech Hunter